Indication
Nasal
2 clinical trials
2 products
Product
STI-3031Clinical trial
An Open-label, Multicenter, Global Phase 2 Basket Study to Investigate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of STI-3031 in Patients With Selected Relapsed or Refractory Malignancies.Status: Withdrawn, Estimated PCD: 2024-01-01
Clinical trial
Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study.Status: Not yet recruiting, Estimated PCD: 2024-09-01
Product
Mepolizumab